1. Home
  2. RPTX vs CAAS Comparison

RPTX vs CAAS Comparison

Compare RPTX & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • CAAS
  • Stock Information
  • Founded
  • RPTX 2016
  • CAAS N/A
  • Country
  • RPTX Canada
  • CAAS China
  • Employees
  • RPTX N/A
  • CAAS N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • CAAS Auto Parts:O.E.M.
  • Sector
  • RPTX Health Care
  • CAAS Consumer Discretionary
  • Exchange
  • RPTX Nasdaq
  • CAAS Nasdaq
  • Market Cap
  • RPTX 119.7M
  • CAAS 111.1M
  • IPO Year
  • RPTX 2020
  • CAAS N/A
  • Fundamental
  • Price
  • RPTX $3.35
  • CAAS $4.18
  • Analyst Decision
  • RPTX Strong Buy
  • CAAS
  • Analyst Count
  • RPTX 2
  • CAAS 0
  • Target Price
  • RPTX $17.50
  • CAAS N/A
  • AVG Volume (30 Days)
  • RPTX 130.0K
  • CAAS 101.8K
  • Earning Date
  • RPTX 11-07-2024
  • CAAS 11-08-2024
  • Dividend Yield
  • RPTX N/A
  • CAAS N/A
  • EPS Growth
  • RPTX N/A
  • CAAS 23.48
  • EPS
  • RPTX N/A
  • CAAS 1.19
  • Revenue
  • RPTX $68,683,000.00
  • CAAS $594,703,000.00
  • Revenue This Year
  • RPTX $16.85
  • CAAS $4.97
  • Revenue Next Year
  • RPTX N/A
  • CAAS N/A
  • P/E Ratio
  • RPTX N/A
  • CAAS $3.81
  • Revenue Growth
  • RPTX N/A
  • CAAS 8.99
  • 52 Week Low
  • RPTX $2.71
  • CAAS $3.04
  • 52 Week High
  • RPTX $8.49
  • CAAS $4.97
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 50.76
  • CAAS 55.00
  • Support Level
  • RPTX $3.07
  • CAAS $4.29
  • Resistance Level
  • RPTX $3.45
  • CAAS $4.58
  • Average True Range (ATR)
  • RPTX 0.21
  • CAAS 0.28
  • MACD
  • RPTX -0.03
  • CAAS -0.02
  • Stochastic Oscillator
  • RPTX 36.36
  • CAAS 49.25

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: